Twist Bioscience: T. Rowe Price reports 9.2% stake
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Twist Bioscience Corp. (TWST) is the issuer in an amended Schedule 13G where reporting person T. Rowe Price Associates, Inc. reports an aggregate beneficial-ownership amount of 6,084,637 shares, or 9.2% of the class. The report lists sole voting power over 5,738,489 shares and sole dispositive power over 6,084,637 shares. T. Rowe Price Associates states that the report is not an admission of beneficial ownership and expressly denies being the beneficial owner.
Key Figures
Key Terms
beneficial ownership regulatory
Sole Dispositive Power regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.